Guideline Panel Meeting: Premature Ejaculation (2019)
The Premature Ejaculation Guideline Panel will be meeting to develop the statements and guideline to be released at the Annual Meeting in 2020.
After participating in this activity, participants will be able to:
- Expand and update urology knowledge base
- Analyze clinical skills and patient care methods towards improving their quality
- Identify methods to improve teaching skills from familiarity with the most recent information and its clinical application
- Demonstrate written communication skills from exposure to peer review of written materials
- Implement improved critical thinking skills
Day 1: October 10, 2019
8:00am Welcome & Introductions Leila Rahimi
8:10am Conflict of Interest Disclosures and Panel Responsibilities Leila Rahimi
8:30am Guidelines Stages Overview Leila Rahimi
8:45am Review of Statement Development Leila Rahimi
9:00am Evidence Report Overview Dr. Roger Chou
10:00am Evidence Report Discussion/Statement Development Panel
10:30am Break (10 min)
12:30pm Lunch (working)
1:00pm Guideline Statement Development Panel
2:45pm Break (10 min)
5:00pm Recap and Day 2 Agenda Panel
5:15pm Shuttle Departs AUA to hotel
6:30pm Shuttle departs from hotel to dinner
Day 2: October 11, 2019
8:30am Drafting Guideline Statements CONT’D Panel
10:30am Break (10 min)
11:00am Discussion of Intro/Future Directions Panel
11:30am Discussion of Diagnostic/ Treatment Algorithm Panel
12:15pm Next Steps Leila Rahimi
12:30pm Meeting Adjourned
Alan Shindel, MD
Journal of Sexual Medicine
Sexual Medicine Society of North America
Meeting Participant or Lecturer
|Roger Chou, Methodologist||Nothing to disclose|
Education Council Disclosures:
Victor Nitti, MD
Scientific Study or Trial
Michael Abern, MD
Dept. of Defense Prostate Cancer Research Program
Scientific study or Trial, Consultant or Advisor
American Urological Association Office of Edu
Consultant or Advisor
Leila Rahimi – Staff
Nothing to disclose
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this Committee learning activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Committee or its subgroup
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Special Assistance/Dietary Needs: The American Urological Association complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
- 11.00 AMA PRA Category 1 Credit™
- 11.00 Non-Physician Participation